Oesophageal Adenocarcinoma Talk

You might also like

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 23

Leo Alexandre

ACF in Gastroenterology

April 2013
Outline

• What is inflammatory bowel disease?

• The genetic and environmental contribution to inflammatory


bowel disease aetiology?

• Do these explain the rising trends?


Oesophageal cancer: two diseases

Squamous cell carcinoma Adenocarcinoma

Lagergren J. BMJ 2010;341:bmj.c6280


Prognosis of oesophageal adenocarcinoma

• Majority present with locally advanced or metastatic disease

• Overall five-year survival less than 20%

• 39% suitable for curative surgery


- 46% recurrence within 1 year
- 47% five-year survival at best
Incidence of oesophageal adenocarcinoma

Age-adjusted annual incidence of oesophageal adenocarcinoma (per 100,000)

Curado A. IARC 2007; 4: 160.


Trends in the annual incidence of oesophageal adenocarcinoma in
England and Wales

Lepage C. Am J Gastroenterol 2008; 103: 2694-9.


Symptoms

• Progressive dysphagia

• Weight loss

• Regurgitation

• Odynophagia

• Hoarseness

• Cough
Patient pathway

Gastroscopy
Gastroscopy indicating
indicating oesophageal
oesophageal cancer
cancer

CT
CT staging,
staging, endoscopic
endoscopic ultrasound,
ultrasound, PET
PET scan,
scan, laparoscopy
laparoscopy

Multidisciplinary
Multidisciplinary team
team approach:
approach: radiologists,
radiologists, pathologists,
pathologists,
oncologists,
oncologists, upper
upper GIGI surgeons,
surgeons, gastroenterologists,
gastroenterologists, specialist
specialist
nurses,
nurses, dieticians
dieticians

Curative
Curative or
or palliative
palliative approaches:
approaches: Oesophagectomy
Oesophagectomy or or
endoscopic
endoscopic mucosal
mucosal resection,
resection, chemotherapy,
chemotherapy, radiotherapy,
radiotherapy,
endoscopic
endoscopic stenting,
stenting, end-of-life
end-of-life care
care
Mechanisms for carcinogenesis

Smoking
Reflux

Obesity
Is reflux a risk factor?

Cases = 189
Controls = 820
Lagergren J. N Engl J Med 1999; 340: 825-31.
Barrett’s Oesophagus

Normal squamous mucosa Barrett’s oesophagus (columnar lined oesophagus)


Barrett’s Oesophagus is pre-malignant

• 30-fold increased risk of OAC


• 1 per 300 patients per year develop OAC

n = 3345
23 984 patient-years

Fitzgerald RC. Aliment Pharmacol Ther 2001; 15: 269-76.


Desai TK. Gut 2012; 61: 970-6.
How obesity could be linked to carcinogenesis
Supportive evidence for obesity

Renehan AG. Lancet 2008; 371: 569-78.


Synergy of reflux and obesity

Cases = 367
Controls = 1580 Whiteman DC. Gut 2008; 57: 173-80.
Smoking is carcinogenic

Cases = 367
Controls = 1580 Whiteman DC. Gut 2008; 57: 173-80.
Explaining trends: reflux

Prevalence of at least weekly heartburn and/or acid regurgitation and publication date

El-Serag HB. Clin Gastroenterol Hepatol 2007; 5: 17-26.


Explaining trends: obesity

Overweight

Obese
Percent

OBESITY AND OAC GRAPH Morbid obese

Year

Age-adjusted trends in overweight, obese and morbid obese categories in the US

Flegal KM. JAMA 2010; 303: 235-41.


Explaining trends: smoking

Smoking Prevalence by sex, Great Britain, 1948-2010

Office for national statistics


Conclusions

• OAC is an important global healthcare problem

• Established risk factors: reflux, obesity, smoking

• Rising obesity does not alone explain changing epidemiology of OAC

• Unidentified risk factors

• Huge research opportunity


Thank you for listening

You might also like